ROYAL BANK OF CANADA - TRANSLATE BIO INC ownership

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TRANSLATE BIO INC
ValueSharesWeighting
Q2 2021$834,000
+89.1%
30,316
+13.3%
0.00%
Q1 2021$441,000
+27.5%
26,759
+42.6%
0.00%
Q4 2020$346,000
+130.7%
18,767
+70.6%
0.00%
Q3 2020$150,000
-29.6%
11,000
-7.4%
0.00%
Q2 2020$213,000
+97.2%
11,884
+10.3%
0.00%
Q1 2020$108,000
+535.3%
10,772
+420.4%
0.00%
Q4 2019$17,000
+183.3%
2,070
+245.0%
0.00%
Q3 2019$6,000
-96.1%
600
-96.0%
0.00%
Q1 2019$153,000
+35.4%
15,0000.0%0.00%
Q4 2018$113,000
+8.7%
15,000
+43.7%
0.00%
Q3 2018$104,00010,4390.00%
Other shareholders
TRANSLATE BIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,437,601$24,376,00011.53%
DAFNA Capital Management LLC 151,739$1,517,0000.62%
Bain Capital Public Equity Management, LLC 738,543$7,385,0000.52%
Baupost Group 6,491,287$62,393,0000.48%
Rock Springs Capital Management LP 1,009,179$10,092,0000.36%
SPHERA FUNDS MANAGEMENT LTD. 276,639$2,766,0000.32%
Cormorant Asset Management, LP 454,550$4,546,0000.30%
Artal Group S.A. 600,000$6,000,0000.16%
Perceptive Advisors 500,000$5,000,0000.13%
ArrowMark Colorado Holdings LLC 367,744$3,677,0000.03%
View complete list of TRANSLATE BIO INC shareholders